Join
Live feed
·
PRReleasevia Quantisnow
BridgeBio Pharma Inc. logo
Helix Acquisition Corp. II logo

Helix Acquisition Corp. II Retains More than 60% of Trust Account after Redemptions in connection with Business Combination with BridgeBio Oncology Therapeutics

ByQuantisnow·Wall Street's wire, on your screen.
BBIO· BridgeBio Pharma Inc.HLXB· Helix Acquisition Corp. II
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BBIO (BridgeBio Pharma Inc.), HLXB (Helix Acquisition Corp. II) and more on Quantisnow.